Community
Following my last post in relation to the G20 summit in Seoul, I wanted to share some further thoughts, as it is clear that because of the diverse economic and regulatory environments in the G20, there is no “one size fits all” guideline for institutions trying to comply with Basel III.
It is clear that many of the G20 countries will not wait for more certainty around Basel III and will push forward independently with specific requirements. The underlying assumption is that regulators are not waiting for the starting gun to put pressure on the systemic key players, as evidenced by the Swiss example, the Internal Liquidity Adequacy Assessment (ILAA) in the UK, and the Dodd-Frank regulation in the US.
Even if Basel III remains unclear in some areas and requires further work from the regulators, banks will not use the “wait and see” approach as commonly used for implementing Basel II. Instead they are adopting a proactive approach for complying efficiently with the new regulatory requirements, despite the seemingly long period until the final implementation deadline.
Today, there are three main areas where banks are improving their risk management issues: improving the quality of their enterprise-wide data, enhancing their risk management policies, and embedding an appropriate awareness of risk culture throughout their organisation. Improving these processes is likely to result in a stronger foundation and more financial transparency, ensuring banks can successfully enter the Basel III era.
This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author.
Eimear Oconnor COO at Form3 Financial Cloud
07 November
Karla Booe Chief Compliance Officer at Zeta Services Inc.
Kyrylo Reitor Chief Marketing Officer at International Fintech Business
06 November
Konstantin Rabin Head of Marketing at Kontomatik
Welcome to Finextra. We use cookies to help us to deliver our services. You may change your preferences at our Cookie Centre.
Please read our Privacy Policy.